These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29238220)

  • 21. Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance.
    Zaky MY; Fan C; Zhang H; Sun XF
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
    Sutter AP; Maaser K; Höpfner M; Huether A; Schuppan D; Scherübl H
    J Hepatol; 2005 Nov; 43(5):808-16. PubMed ID: 16083991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin use and breast cancer: do we need more evidence and what should this be?
    Bonovas S; Lytras T; Sitaras NM
    Expert Opin Drug Saf; 2014 Mar; 13(3):271-5. PubMed ID: 24517162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.
    Mason NA; Bailie GR; Satayathum S; Bragg-Gresham JL; Akiba T; Akizawa T; Combe C; Rayner HC; Saito A; Gillespie BW; Young EW
    Am J Kidney Dis; 2005 Jan; 45(1):119-26. PubMed ID: 15696451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of statin therapy on colorectal cancer.
    Bardou M; Barkun A; Martel M
    Gut; 2010 Nov; 59(11):1572-85. PubMed ID: 20660702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins in Stroke Prevention: Present and Future.
    Castilla-Guerra L; Del Carmen Fernandez-Moreno M; Colmenero-Camacho MA
    Curr Pharm Des; 2016; 22(30):4638-4644. PubMed ID: 27160755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms.
    Fatehi Hassanabad A
    Transl Lung Cancer Res; 2019 Oct; 8(5):692-699. PubMed ID: 31737505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study.
    Denoyelle C; Vasse M; Körner M; Mishal Z; Ganné F; Vannier JP; Soria J; Soria C
    Carcinogenesis; 2001 Aug; 22(8):1139-48. PubMed ID: 11470741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
    Liu B; Yi Z; Guan X; Zeng YX; Ma F
    Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins and breast cancer: a smoking gun or guilt by association?
    Ahmed MH; Osman MM; Alokail MS
    Expert Opin Drug Saf; 2006 Sep; 5(5):599-601. PubMed ID: 16907648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
    Miida T; Hirayama S; Nakamura Y
    J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
    Mueck AO; Seeger H; Wallwiener D
    Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins and breast cancer: may matrix metalloproteinase be the missing link.
    Mannello F; Tonti GA
    Cancer Invest; 2009 May; 27(4):466-70. PubMed ID: 19219650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies.
    Mansourian M; Haghjooy-Javanmard S; Eshraghi A; Vaseghi G; Hayatshahi A; Thomas J
    J Pharm Pharm Sci; 2016; 19(1):72-81. PubMed ID: 27096694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of statins on cancer cells--review.
    Matusewicz L; Meissner J; Toporkiewicz M; Sikorski AF
    Tumour Biol; 2015 Jul; 36(7):4889-904. PubMed ID: 26002574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.